CLINICAL_TRIALS
trial_result
· 2017-04-11
Clinical Trial Update: Transcranial Doppler (TCD) With Transfusions Changing to Hydroxyurea [Phase 3]
Summary
A Phase 3 trial investigating a shift from transfusions to hydroxyurea in sickle cell anemia was terminated, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Sickle Cell Anemia | Phase 3 | Status: TERMINATED | Results posted: 2017-04-11